Nurse Intervention Trial: The Evaluation of Usefulness of a Headache Nurse

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This randomized open-label prospective study focus on headache patients initiating preventive treatment, where the treating physician identifies a need for follow-up visits in specialized healthcare. The study will clarify whether the implementation (compliance) and overall satisfaction of the patient are better with follow-up by a headache nurse compared to standard follow-up. Patients with signed written consent will be randomised to either group a: Telephone calls from nurse after two and 6 week or B. Patient-initiated follow-up by their general practitioner.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 90
Healthy Volunteers: f
View:

• One of the following headache diagnoses based on the International Classification of Headache Disorders, third edition (ICDH3): G44.2 Chronic tension-type headache and/or G43 Episodic and chronic migraine, G44.0 Episodic and chronic cluster headache, G44.8 Hemicrania Continua

• Indication for preventive medication where there is at least one alternative with the need for follow-up assessment of effectiveness.

Locations
Other Locations
Norway
St. Olavs Hospital HF
RECRUITING
Trondheim
Contact Information
Primary
Knut Hagen
knut.hagen@stolav.no
95401579
Backup
Erling Tronvik
erling.tronvik@ntnu.no
40008646
Time Frame
Start Date: 2023-04-21
Estimated Completion Date: 2027-12-31
Participants
Target number of participants: 400
Treatments
Active_comparator: Telephone by nurse
The headache patients will be contacted by nurse by phone after approximately 2 week and 6 week after start of preventive medical treatment. The patient will have a follow-up visit by neurologist after 3 months.
No_intervention: Patient-initiated follow-up
The headache patient contact their general practitioner (GP) and/or the neurologist by a study-specific email if they have questions regarding the preventive medical treatment
Sponsors
Collaborators: St. Olavs Hospital, Haukeland University Hospital, Oslo University Hospital
Leads: Norwegian University of Science and Technology

This content was sourced from clinicaltrials.gov